89Zr-labeled NY009 PET Imaging in Patients
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY009 PET Imaging in patients
Cancer
DRUG: 89Zr-NY009
Evaluation of tissue distribution of 89Zr-NY009, Biodistribution of 89Zr-NY009 evaluated by radioactive uptake values (standardized uptake values, SUVs) in various organs during repeated 89Zr-PET scans will be reported., 7 days
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY009 PET Imaging in patients